CRINETICS PHARMACEUTICALS INC (CRNX) — insider trading
Health Care · NASDAQ
CRINETICS PHARMACEUTICALS INC (CRNX) has 151 reported SEC Form 4 insider transactions in our data (latest 2026-09-01).
Recent Form 4 transactions
Showing the 100 most recent of 151 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 17,500 | $66.71 | $1.17M | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 17,500 | $64.77 | $1.13M | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 12,500 | $61.77 | $772.1K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer (derivative) | 12,500 | $61.76 | $772.0K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | WIERENGA WENDELL | Director | Disposition to the issuer | 116,146 | $85.00 | $9.87M | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 8,750 | $66.71 | $583.7K | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer (derivative) | 35,000 | $56.69 | $1.98M | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Disposition to the issuer | 13,300 | $85.00 | $1.13M | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 17,500 | $64.77 | $1.13M | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 12,500 | $61.77 | $772.1K | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer (derivative) | 25,000 | $60.85 | $1.52M | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | Okey Stephanie | Director | Disposition to the issuer | 6,400 | $85.00 | $544.0K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 17,500 | $66.71 | $1.17M | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 17,500 | $64.77 | $1.13M | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 12,500 | $61.77 | $772.1K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer (derivative) | 12,500 | $61.76 | $772.0K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | Nichols Weston | Director | Disposition to the issuer | 16,300 | $85.00 | $1.39M | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer (derivative) | 2,092 | $83.09 | $173.8K | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | Fust Matthew K | Director | Disposition to the issuer | 22,836 | $85.00 | $1.94M | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 4,375 | $66.71 | $291.9K | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer (derivative) | 35,000 | $65.70 | $2.30M | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer | 5,925 | $85.00 | $503.6K | Form 4 |
| 2026-09-01 | Deardorf Caren | Director | Disposition to the issuer | 16,300 | $85.00 | $1.39M | Form 4 |
| 2026-09-01 | Kalofonos Isabel | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 55,000 | $41.21 | $2.27M | Form 4 |
| 2026-09-01 | Kalofonos Isabel | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 97,500 | $44.41 | $4.33M | Form 4 |
| 2026-09-01 | Kalofonos Isabel | Officer (Chief Commercial Officer) | Disposition to the issuer | 34,000 | $85.00 | $2.89M | Form 4 |
| 2026-09-01 | Kalofonos Isabel | Officer (Chief Commercial Officer) | Disposition to the issuer | 1,669 | $85.00 | $141.9K | Form 4 |
| 2026-09-01 | Schilke Tobin | Officer (Chief Financial & Infra. Ofcr.) | Disposition to the issuer (derivative) | 50,000 | $41.21 | $2.06M | Form 4 |
| 2026-09-01 | Schilke Tobin | Officer (Chief Financial & Infra. Ofcr.) | Disposition to the issuer (derivative) | 80,000 | $51.25 | $4.10M | Form 4 |
| 2026-09-01 | Schilke Tobin | Officer (Chief Financial & Infra. Ofcr.) | Disposition to the issuer | 71,471 | $85.00 | $6.08M | Form 4 |
| 2026-09-01 | Schilke Tobin | Officer (Chief Financial & Infra. Ofcr.) | Disposition to the issuer | 7,956 | $85.00 | $676.3K | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 228,000 | $41.21 | $9.40M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 313,000 | $48.14 | $15.07M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 240,000 | $41.49 | $9.96M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 287,700 | $65.36 | $18.80M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 244,205 | $64.98 | $15.87M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 259,058 | $69.71 | $18.06M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 195,578 | $62.39 | $12.20M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer (derivative) | 172,281 | $59.81 | $10.30M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 176,663 | $85.00 | $15.02M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 80,000 | $85.00 | $6.80M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 111,100 | $85.00 | $9.44M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 111,100 | $85.00 | $9.44M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 111,100 | $85.00 | $9.44M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 111,100 | $85.00 | $9.44M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 100,000 | $85.00 | $8.50M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 110,000 | $85.00 | $9.35M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 106,000 | $85.00 | $9.01M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 136,805 | $85.00 | $11.63M | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 1,000 | $85.00 | $85.0K | Form 4 |
| 2026-09-01 | Struthers Richard Scott | Director, Officer (President & CEO) | Disposition to the issuer | 248,043 | $85.00 | $21.08M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 47,000 | $41.21 | $1.94M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 65,000 | $48.14 | $3.13M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 87,000 | $41.49 | $3.61M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 110,000 | $65.36 | $7.19M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 77,000 | $64.98 | $5.00M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 15,000 | $61.81 | $927.1K | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 85,000 | $69.71 | $5.93M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 60,000 | $62.39 | $3.74M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 56,250 | $59.81 | $3.36M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 74,540 | $75.72 | $5.64M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer (derivative) | 90,514 | $83.09 | $7.52M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer | 79,650 | $85.00 | $6.77M | Form 4 |
| 2026-09-01 | Betz Stephen F. | Officer (Chief Scientific Officer) | Disposition to the issuer | 58,286 | $85.00 | $4.95M | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 9,730 | $49.13 | $478.0K | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 10,350 | $52.67 | $545.1K | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 12,500 | $40.29 | $503.6K | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 17,500 | $64.68 | $1.13M | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 17,500 | $66.71 | $1.17M | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 17,500 | $64.77 | $1.13M | Form 4 |
| 2026-09-01 | Bedrosian Camille L | Director | Disposition to the issuer (derivative) | 25,000 | $68.92 | $1.72M | Form 4 |
Ask the chat about CRNX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CRINETICS PHARMACEUTICALS INC (CRNX).
Last updated 2026-09-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.